Par Drugs and Chemicals Operational Benchmarking
₹117.75-6.01%close, 9 Oct 2026
- Market cap
- ₹145 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹84.78 – ₹158.96
Par Drugs and Chemicals compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Par Drugs and Chemicals sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Par Drugs and Chemicals Limited | ₹117.75 | 22.5 | 145 | 1.2% | 36.22 | 14.5% |
| Median (1 Cos) | ₹117.75 | 22.5 | 145 | 1.2% | 36.22 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Pfizer Limited operational benchmarking
- Orchid Pharma Limited operational benchmarking
- Procter & Gamble Hygiene and Health Care Limited operational benchmarking
- Onesource Specialty Pharma Limited operational benchmarking
- Poly Medicure Limited operational benchmarking
- Narayana Hrudayalaya Limited. operational benchmarking
Trade Par Drugs and Chemicals With ATS
Track PAR live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.